Merck MRK will report its first-quarter 2024 earnings on April 24, before market open. The Zacks Consensus Estimate for first ...

Merck MRK reported first-quarter 2025 adjusted earnings per share (EPS) of $2.22, which beat the Zacks Consensus Estimate of ...

A steep fall in demand from China drove a 41% decline in MSD Q1 2025 sales of its human papillomavirus (HPV) vaccines Gardasil and Gardasil 9, marking a continued setback for the company’s ...

The drugmaker is still dealing with the fallout over its HPV vaccine Gardasil in China, where a drop in demand forced it to halt shipments and rescind its previous forecast of $11 billion in ...

Why it matters: Investors have been particularly concerned about demand for HPV vaccine Gardasil in China, with uncertainty around pharmaceutical tariffs also weighing on shares. Gardasil's 41% ($ ...

He noted that the HPV vaccine is available free of charge in PHC facilities across the country, like every other vaccine in the national immunisation schedule. The federal government on Tuesday ...

1436 GMT – Merck’s struggles with Gardasil aren’t easing up. The drug maker disclosed 1Q sales of the treatment, which prevents cancers caused from the human papillomavirus, declined 41% to ...

The INJ token is central to the injective ecosystem, serving functions that include governance, security and facilitating transactions. For March 2025, analysts forecast a 0.68% price increase for ...

He said the HPV vaccine was introduced in October 2023 and May 2024, targeting girls aged nine to 14 years. He said so far, over 13 million adolescent girls have received the vaccine across all 36 ...

Clinical trials to test vaccine against Alzheimer's-promoting tau protein Date: April 23, 2025 Source: University of New Mexico Health Sciences Center Summary: Researchers hope to launch human ...

Weight loss injections are a popular option for those hoping to shed pounds quickly and effectively. These medications alter appetite and metabolism to help support long-term weight loss — but ...